Is the new Teva x Ugg collection fashion-forward or just plain ugly? - MarketWatch
Is the new Teva x Ugg collection fashion-forward or just plain ugly? - MarketWatch
Teva Pharmaceuticals reports earnings on Wednesday. Here's what to expect - MarketWatch
Teva's generic EpiPen approved in the U.S., with perfect timing - MarketWatch
Teva Pharmaceutical Settles Opioid Suit With West Virginia - MarketWatch
Israel stocks rise, led by Teva, ICL - MarketWatch
Teva shares surge on corporate shake-up - MarketWatch
Teva Pharmaceutical Shares Real-World Data Of ProAir Digihaler In Asthma Patients
Teva stock drops on guidance, manufacturing problems - MarketWatch
Israel stocks lower; Ness agrees to takeover - MarketWatch
Warren Buffett's firm trims stakes in drug makers, finance companies - MarketWatch
Teva releases generic version of Mylan's EpiPen in limited doses in the U.S. - MarketWatch
Tel Aviv losing streak extends into third day - MarketWatch
Teva Pharmaceuticals stock falls 11% after earnings miss - MarketWatch
Billionaire health-care investor Phillip Frost charged by SEC with pump-and-dump schemes - MarketWatch
Teva Pharmaceutical TEVA Pivots Trading Plans and Risk Controls - MarketWatch
Why Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Stock Is Coming Back
Teva Pharmaceuticals - Wikipedia
What To Do After TEVA Stock Falls Below $10 Again (NYSE:TEVA) | Seeking Alpha
Teva beats first-quarter expectations but still has the same old problems - MarketWatch
Mylan tries to fend off Teva with bigger bid for Perrigo - MarketWatch
Teva beats first-quarter expectations but still has the same old problems - MarketWatch
Teva Pharmaceutical to pay $110 mln to settle opioid charges in W. Va. - MarketWatch
Teva Pharmaceutical to pay $110 mln to settle opioid charges in W. Va. - MarketWatch
There's scant evidence so far for chloroquine as a COVID-19 drug — but there's already a shortage - MarketWatch
